Lindsey Sablatura, PhD
Lindsey Sablatura is a postdoctoral research fellow in the Sirianni lab group. She joined the lab in September 2020. Her work in the lab focuses on targeting leptomeningeal metastasis in medulloblastoma and intrathecal delivery of radiation sensitizing nanoparticles in pediatric neuro-oncology using Vyxeos, a combination of daunorubicin and cytarabine drugs used for chemotherapy.
[PDF]. Chaudhuri S, Fowler MJ, Baker C, Stopka SA, Regan MS, Sablatura LK, Broughton CW, Knight BE, Stabenfeldt SE, Agar NYR, Sirianni RW*. Beta-cyclodextrin-poly(beta-amino ester) nanoparticles are a generalizable strategy for high loading and sustained release of HDAC inhibitors in the CNS in press, ACS Applied Materials and Interfaces. IF = 8.76